Stephen I. Wasserman
#154,808
Most Influential Person Now
Stephen I. Wasserman's AcademicInfluence.com Rankings
Stephen I. Wassermanphilosophy Degrees
Philosophy
#8716
World Rank
#12147
Historical Rank
Logic
#5744
World Rank
#7169
Historical Rank
Stephen I. Wassermanbiology Degrees
Biology
#11862
World Rank
#15290
Historical Rank
Immunology
#779
World Rank
#802
Historical Rank
Download Badge
Philosophy Biology
Stephen I. Wasserman's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Immunology Stanford University
Why Is Stephen I. Wasserman Influential?
(Suggest an Edit or Addition)Stephen I. Wasserman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cytokines in symptomatic asthma airways. (1992) (789)
- Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. (2011) (613)
- Tiotropium bromide step-up therapy for adults with uncontrolled asthma. (2010) (509)
- Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. (1976) (404)
- Increased biosynthesis of platelet-activating factor in activated human eosinophils. (1984) (401)
- Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. (1991) (296)
- Mediators of immediate hypersensitivity. (1983) (280)
- Immunologic Release of β-Hexosaminidase and β-Glucuronidase from Purified Rat Serosal Mast Cells (1979) (256)
- Asthma in the elderly: Current understanding and future research needs—a report of a National Institute on Aging (NIA) workshop (2011) (233)
- Oral disodium cromoglycate in the treatment of systemic mastocytosis. (1979) (202)
- Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial (2009) (192)
- Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. (1974) (179)
- Association of platelet-activating factor with primary acquired cold urticaria. (1985) (178)
- Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. (2012) (174)
- Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. (1977) (169)
- Adenosine release from stimulated mast cells. (1984) (163)
- Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. (1975) (159)
- Cell association of complexes of chymase, heparin proteoglycan, and protein after degranulation by rat mast cells. (1981) (149)
- Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticaria. (1980) (144)
- Activities of enzymes that metabolize platelet-activating factor (1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore. (1982) (143)
- Tumor-associated eosinophilotactic factor. (1974) (140)
- Immunologic release of chemical mediators from human nasal polyps. (1973) (139)
- Isolation and characterization of heparin from human lung. (1979) (139)
- A trial of clarithromycin for the treatment of suboptimally controlled asthma. (2010) (135)
- Evaluation of role played by mediators of immediate hypersensitivity in exercise-induced asthma. (1980) (133)
- Molecular Determinants of T Cell Epitope Recognition to the Common Timothy Grass Allergen (2010) (131)
- Release of chemical mediators from partially purified human lung mast cells. (1976) (129)
- Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. (1986) (116)
- Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients. (2013) (108)
- Airway levels of mast cell-derived mediators in exercise-induced asthma. (1990) (107)
- The release of four mediators of immediate hypersensitivity from human leukemic basophils. (1975) (104)
- Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A). (1974) (104)
- Predictors of response to tiotropium versus salmeterol in asthmatic adults. (2013) (96)
- Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. (1991) (92)
- Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. (1979) (91)
- The mast cell and synovial inflammation (1984) (83)
- Differing effects of apical and basolateral adenosine on colonic epithelial cell line T84. (1989) (82)
- Immune-related intestinal Cl- secretion. I. Effect of histamine on the T84 cell line. (1988) (79)
- TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media (2009) (78)
- Transforming growth factor-beta 1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation. (1989) (78)
- FORMATION OF SLOW-REACTING SUBSTANCE OF ANAPHYLAXIS IN HUMAN LUNG TISSUE AND CELLS BEFORE RELEASE (1974) (76)
- Myeloid differentiation primary response gene 88 is required for the resolution of otitis media. (2008) (74)
- Adenosine receptors on mouse bone marrow-derived mast cells: functional significance and regulation by aminophylline. (1984) (74)
- Differential effects of a partially purified preparation of slow-reacting substance of anaphylaxis on guinea pig tracheal spirals and parenchymal strips. (1979) (71)
- Generation and partial characterization of eosinophil chemotactic activity and neutrophil chemotactic activity during early and late-phase asthmatic response. (1986) (71)
- A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma. (1996) (67)
- Immune-related intestinal chloride secretion. II. Effect of adenosine on T84 cell line. (1990) (67)
- Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity. (1975) (65)
- Innate Signaling in Otitis Media: Pathogenesis and Recovery (2010) (64)
- Aeroallergen sensitization correlates with PC(20) and exhaled nitric oxide in subjects with mild-to-moderate asthma. (2008) (64)
- Role of mast cells in otitis media. (2005) (61)
- Mast cell biology. (1990) (61)
- A double-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma. North American Tilade Study Group. (1990) (61)
- Modulation of rat serosal mast cell biochemistry by in vivo dexamethasone administration. (1983) (59)
- The heart in anaphylaxis. (1986) (59)
- Secondary Immune Response in the Middle Ear: Immunological, Morphological, and Physiological Observations (1986) (59)
- Mast cells and airway inflammation in asthma. (1994) (58)
- Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid. (1990) (54)
- The transcriptome of a complete episode of acute otitis media (2015) (53)
- The role of DNA sensing and innate immune receptor TLR9 in otitis media (2012) (48)
- Identification of sulfated mucopolysaccharides including heparin in the lesional skin of a patient with mastocytosis. (1980) (48)
- Biochemical and functional characterization of proteoglycans isolated from basophils of patients with chronic myelogenous leukemia. (1984) (47)
- The eosinophil and the lung. (1982) (46)
- Release of platelet factor 4 into the blood after cold challenge of patients with cold urticaria. (1984) (45)
- Arylsulfatase B of human lung. Isolation, characterization, and interaction with slow-reacting substance of anaphylaxis. (1976) (44)
- Mast cell-mediated inflammation in asthma. (1989) (43)
- Mast Cell-Derived Mediators: Structural and Functional Diversity and Regulation of Expression (1976) (43)
- CC Chemokine Ligand 3 Overcomes the Bacteriocidal and Phagocytic Defect of Macrophages and Hastens Recovery from Experimental Otitis Media in TNF−/− Mice (2010) (43)
- Characterization of the rat mast cell beta-adrenergic receptor in resting and stimulated cells by radioligand binding. (1982) (42)
- The use of in vitro tests for IgE antibody in the specific diagnosis of IgE-mediated disorders and in the formulation of allergen immunotherapy. American Academy of Allergy and Immunology. (1992) (41)
- Physical urticaria/angioedema: an experimental model of mast cell activation in humans. (1980) (41)
- Predicting worsening asthma control following the common cold (2008) (40)
- The role of transcription factors in allergic inflammation. (2002) (40)
- Differential effects of protoporphyrin and uroporphyrin on murine mast cells. (1987) (40)
- The response to human rIL‐1, rIL‐2, and rTNF in the middle ear of guinea pigs (1991) (40)
- A neutrophil immobilizing factor derived from human leukocytes. II. Specificity of action on polymorphonuclear leukocyte mobility. (1973) (40)
- Inhibition of rat mast cell arachidonic acid cyclooxygenase by dapsone. (1983) (39)
- The Toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery (2009) (38)
- Histamine-Induced Middle Ear Effusion and Mucosal Histopathology in the Guinea Pig (1985) (38)
- Mouse models of induced otitis media (2006) (37)
- The functional and physicochemical characterization of three eosinophilotactic activities released into the circulation by cold challenge of patients with cold urticaria. (1982) (37)
- Inhibition of neutrophil chemotaxis in association with experimental angioedema in patients with cold urticaria: a model of chemotactic deactivation in vivo. (1979) (37)
- The lung mast cell: its physiology and potential relevance to defense of the lung. (1980) (36)
- Innate Immunity: Orchestrating Inflammation and Resolution of Otitis Media (2016) (36)
- Release of arylsulfatase A but not B from rat mast cells by noncytolytic secretory stimuli. (1978) (35)
- Chemotactic Deactivation of Human Eosinophils by the Eosinophil Chemotactic Factor of Anaphylaxis 1 (1975) (32)
- Identification and characterization of arylsulfatase A and B of the rat basophil leukemia tumor. (1977) (32)
- The inflammasome adaptor ASC contributes to multiple innate immune processes in the resolution of otitis media (2015) (31)
- Eosinophils and immunologic lung disease. (1981) (29)
- The human lung mast cell. (1984) (29)
- Obesity's effect on asthma extends to diagnostic criteria (2017) (28)
- Neutrophil chemotactic activity generation by alveolar macrophages after bleomycin injury. (1984) (26)
- Evaluation of household dust mite exposure and levels of specific IgE and IgG antibodies in asthmatic patients enrolled in a trial of immunotherapy. (1996) (25)
- Histamine release from rodent and human mast cells induced by protoporphyrin and ultraviolet light: studies of the mechanism of mast‐cell activation in erythropoietic protoporphyria (1990) (25)
- Rat lung cholinergic receptor: characterization and regulation by corticosteroids. (1982) (25)
- The mast cell and synovial inflammation. Or, what's a nice cell like you doing in a joint like this? (1984) (25)
- TNFA deletion alters apoptosis as well as caspase 3 and 4 expression during otitis media (2011) (23)
- Rosuvastatin: an independent analysis of risks and benefits. (2006) (22)
- Biologic therapies for the treatment of asthma. (2006) (21)
- The isolation, identification and characterization of sulfated glycosaminoglycans synthesized in vitro by human eosinophils. (1982) (21)
- Isolation and characterization of sulphated mucopolysaccharides from rat leukaemic (RBL-1) basophils. (1980) (20)
- A Mouse Model of Otitis Media Identifies HB-EGF as a Mediator of Inflammation-Induced Mucosal Proliferation (2014) (20)
- Substances which modulate leukocyte migration are present in CSF during meningitis (1979) (20)
- Functional and biochemical characterization of rat bone marrow derived mast cells. (1988) (19)
- Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol. (1995) (18)
- Cromolyn inhibition of mediator release in mast cells derived from mouse bone marrow. (1986) (18)
- Serum eosinophilotactic activity in eosinophilic fasciitis. (1982) (17)
- Modulation of the immunological release of the eosinophil chemotactic factor of anaphylaxis from human lung. (1974) (17)
- Asthma: a disorder of adrenergic receptors? (1990) (17)
- Mast cells in allergic diseases and mastocytosis. (1982) (17)
- C-Jun N-terminal kinase (JNK) isoforms play differing roles in otitis media (2014) (16)
- The Mast Cell: Its Diversity of Chemical Mediators (1980) (16)
- The effect of complement depletion on immunologically mediated middle ear effusion and inflammation. (1986) (16)
- 31 Evaluation of cetirizine in the treatment of patients with seasonal allergic rhinitis (1988) (16)
- URTICARIA/ANGIOEDEMA A CONSIDERATION OF PATHOCENESIS AND CLINICAL MANIFESTATIONS (1979) (16)
- Histamine and the preclinical pharmacology of cetirizine. (1987) (15)
- Alteration of rat splenic lymphocyte migration in vitro by the state of microtubule integrity. (1978) (15)
- A STUDY OF ATHEROSCLEROSIS IN A GROUP OF DIABETIC PATIENTS (1950) (13)
- Asthma in a Vietnamese refugee population. (1997) (13)
- Cetirizine therapy for seasonal allergic rhinitis: alternative dosage schedules. (1991) (13)
- Basic mechanisms in asthma. (1988) (12)
- CC chemokine ligand 3 overcomes the bacteriocidal and phagocytic defect of macrophages and hastens recovery from experimental otitis media in TNF−/− mice (2010) (12)
- Alterations of the electrophoretic mobility distribution of rat mast cells after immunologic activation. (1980) (11)
- The regulation of inflammatory mediator production by mast cell products. (1987) (10)
- NOD1/NOD2-mediated recognition of non-typeable Haemophilus influenzae activates innate immunity during otitis media (2019) (10)
- The role of monoclonal antibodies in the treatment of severe asthma (2011) (10)
- Biologic modulators in allergic and autoinflammatory diseases (2011) (10)
- 232 Plasma mediator studies in aspirin sensitive asthma: Lack of a role for the mast cell (1983) (10)
- 1 Histochemical differentiation of human nasal mucosa mast cells from basophil leukocytes (1983) (10)
- Anaphylactic reaction to cytarabine: in vitro evidence that the response is immunoglobulin E mediated. (1984) (10)
- Mast cell and eosinophil mediated damage in bullous pemphigoid. (1989) (10)
- Otitis Media and Nasopharyngeal Colonization in ccl3−/− Mice (2017) (10)
- 37. Assessment of mast cell mediators and pulmonary function in aspirin (ASA)-induced bronchospasm (1978) (9)
- The molecular pathogenesis of bullous pemphigoid. (1987) (9)
- The mast cell and theophylline in asthma. (1985) (9)
- The relevance of neutrophil chemotactic factors to allergic disease. (1979) (9)
- Aminophylline exposure alters mouse bone marrow-derived mast cell adenosine responsiveness. (1986) (9)
- Immunopharmacologic profile of nedocromil sodium. (1995) (8)
- Chemotactic Factors (1990) (8)
- Reconstitution of the Mast Cell Population in W/Wv Mice (2010) (7)
- Chemotactic mediators (1983) (7)
- The allergist in the new millennium. (2000) (7)
- A review of some recent clinical studies with nedocromil sodium. (1993) (6)
- Platelet-activating factor as a mediator of bronchial asthma. (1988) (6)
- American Board of Allergy and Immunology (2013) (5)
- Chronic urticaria--a frustrating but increasingly understandable disorder. (1990) (5)
- 257 – Approach to the Patient with Allergic or Immunologic Disease (2012) (5)
- ABAI's MOC Assessment of Knowledge Program Matures: Adding Value with Continuous Learning and Assessment. (2017) (4)
- 408 Prevalence of dust mites in the homes of asthmatics in several U.S. Geographical regions (1988) (4)
- 352 Cromolyn inhibition of mouse bone marrow-derived mast cell mediator release (1985) (4)
- TNF and MyD88 are Critical to the Clearance of Nontypeable Nontypable Haemophilus Influenzae (NTHi)-Induced Otitis Media via Inflammatory Cell Recruitment and Phagocytosis (2008) (3)
- Proceedings of a roundtable discussion held on January 28, 1995 (1996) (3)
- Mechanisms of mast cell signaling (1993) (3)
- 31. Assessment of clinical competence of the allergist/immunologist. (2003) (3)
- The primary chemical mediators of immediate hypersensitivity: chemical and functional characterization and biochemical events in their generation and release. (1977) (3)
- Role of the PI3K/AKT pathway and PTEN in otitis media. (2019) (2)
- 115 Distinguishing clinical and biochemical characteristics associated with improvement or deterioration of asthma during pregnancy (1985) (2)
- K. Frank Austen, MD, and slow-reacting substance of anaphylaxis in the sulfidopeptide leukotriene era (2006) (2)
- 727 Sensitization and exposure to dust mite allergens of patients admitted to a long term trial of immunotherapy of asthma (1991) (2)
- The allergy archives: pioneer and milestones. The discovery and characterization of the leukotrienes. (2006) (2)
- Board requirements versus National Institutes of Health requirements. (1996) (1)
- The role of eustachian tube dysfunction in immune-mediated middle ear effusion and inflammation. (1985) (1)
- Characterization, activation, and functional importance of mucosal mast cells. (1989) (1)
- Inhaled corticosteroids and likelihood of cataract extraction. (1999) (1)
- Future pharmacologic agents and maneuvers in asthma therapy. (1985) (1)
- Continuous professional development in internal medicine: recertification as a measure of professional accountability and quality improvement. (2000) (1)
- CCL3 Restores Bacterial Clearance in Nontypeable Haemophilus Influenzae (NTHi)-induced Otitis Media in TNF−/− mice (2009) (1)
- Impaired antibacterial function is restored via CCL3 (2009) (1)
- The role of neutrophils in asthma. (1981) (1)
- Mast Cell Dependent Chemotactic Factors in Human Disease (1983) (1)
- 85. Subcellular localization of rat mast cell arylsulfatases A and B (1978) (1)
- Calcium mobilization in activated mast cells monitored by flow cytometric analysis (1990) (1)
- Summary of nedocromil sodium symposium (1993) (1)
- The allergy and immunology milestone project. (2014) (1)
- Workshop 1: Lessons from the past (1986) (1)
- A kinase inhibitor screen identifies signaling pathways regulating mucosal growth during otitis media (2020) (1)
- Biochemical Mediators Of Immediate Type Hypersensitivity (1976) (1)
- The pharmacologic basis of asthma therapy. (1980) (1)
- Mast cell mediators in the blood of patients with asthma. (1985) (1)
- 7KH,Q¿DPPDVRPH$GDSWRU$6&&RQWULEXWHV To Multiple Innate Immune Processes In The Resolution Of Otitis Media (2014) (0)
- MOC CME program. (2011) (0)
- Maintenance of certification and maintenance of professionalism. (2011) (0)
- Allergy-important advances in clinical medicine: venom immunotherapy in children. (1984) (0)
- 14. Dependence of rat splenic lymphocyte migration on microtubule integrity (1978) (0)
- The Role of Mast Cells and Eosinophils in Asthma (1994) (0)
- Allergy-important advances in clinical medicine: eosinophils. (1984) (0)
- Role of the allergist/immunologist as a subspecialist. Committee on the Role of the Allergist/Immunologist as a Subspecialist. (1997) (0)
- The transcriptome of a complete episode of acute otitis media (2015) (0)
- ABAI: How to Use the ABAI WebPortal for Maintenance of Certification (MOC) Activities (2016) (0)
- Contributors (2012) (0)
- Mast cells in the innate immune response of the middle ear (2005) (0)
- R206: The Role of Toll-Like Receptors 2 and 4 in Otitis Media (2006) (0)
- Systemic Allergic Disorders: IgE-Mediated Disorders, Angioedema, Nonsteroidal Anti Inflammatory Drug Sensitivity and Stevens-Johnson Syndrome (2007) (0)
- Anion channel inhibition blocks an early step in mast cell activation (1982) (0)
- C-Jun N-terminal kinase (JNK) isoforms play differing roles in otitis media (2014) (0)
- Workshop D: Present status and future issues/directions of allergy and immunology training programs/academic centers (1992) (0)
- 37 Detection and management of cold urticaria patients at high risk for cold-induced systemic reactions (1985) (0)
- K. Frank Austen, MD, and the biological characterization of slow-reacting substance of anaphylaxis and its molecular identification as the sulfidopeptide leukotrienes (2006) (0)
- What's New with the ABAI? Certification and Maintenance of Certification (2017) (0)
- The Role of MyD88 and TNF-α in the Inflammatory Response in the Middle Ear (2006) (0)
- Characterization of the beta-adrenergic receptor in rat mast cells (1982) (0)
- You Talked and We Listened: The ABAI’s Updated MOC Program Options (2018) (0)
- Nonspecific Immune Response: The Role of Accessory Systems in the Expression and Regulation of Specific Immunity (1984) (0)
- Adenosine release from stimulated mast cells (immediate hypersensitivity/ATP/purines) (0)
- ABAI Certification Leads to Maintenance of Certification (2017) (0)
- Evolution in the ABAI MOC Program (2018) (0)
- Book Review Allergy and Allergic Diseases Edited by A.B. Kay. 1738 pp. in two volumes, illustrated. Boston, Blackwell Science, 1997. $275. 0-86542-867-0 (1998) (0)
- Modulation oftheImmunological Release oftheEosinophil Chemotactic Factor ofAnaphylaxis fromHumanLung (1974) (0)
- Tricyclics and child and adolescent suicides. (1988) (0)
- The mast cell—Introduction (1983) (0)
- Molecular Determinants of T Cell Epitope (2010) (0)
- [3H]Adenosine binding to rat mast cells — pharmacologic and functional characterization (1985) (0)
- Developing an understanding of mast cell biology (2013) (0)
- Heparin from Human Lung (1979) (0)
- Slow Reacting Substance of Anaphylaxis (1989) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stephen I. Wasserman?
Stephen I. Wasserman is affiliated with the following schools:
